Time‐Varying Belatacept Exposure and Its Relationship to Efficacy/Safety Responses in Kidney‐Transplant Recipients

E-ISSN： 1532-6535|92|2|251-257

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.92, Iss.2, 2012-08, pp. : 251-257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Belatacept for kidney transplant recipients

NEPHROLOGY, Vol. 20, Iss. 10, 2015-10 ,pp. : 752-754

John Wiley & Sons Inc

Access to resources Recommend Favorite

Time‐varying maximal proteinuria correlates with adverse cardiovascular events and graft failure in kidney transplant recipients

NEPHROLOGY, Vol. 20, Iss. 12, 2015-12 ,pp. : 945-951

John Wiley & Sons Inc

Access to resources Recommend Favorite

Does belatacept improve outcomes for kidney transplant recipients? A systematic review

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 934-0874, Iss. 11, 2015-11 ,pp. : 1251-1264

John Wiley & Sons Inc

Access to resources Recommend Favorite

Does belatacept improve outcomes for kidney transplant recipients? A systematic review

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 11, 2015-11 ,pp. : 1251-1264

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft Dysfunction

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 10, 2015-10 ,pp. : 2726-2731

John Wiley & Sons Inc

Access to resources Recommend Favorite